共查询到20条相似文献,搜索用时 62 毫秒
1.
AMY K. LEBLANC JON S. WALL FEDERICA MORANDI STEPHEN J. KENNEl ALAN STUCKEY BJOERN JAKOBY DAVID W. TOWNSEND GREGORY B. DANIEL 《Veterinary radiology & ultrasound》2009,50(4):436-441
Positron emission tomography (PET) with 2-deoxy-2-[18 F]fluoro- d -glucose (18 FDG) is an important imaging modality for diagnosis and staging of human neoplastic disease. The purpose of this study is to describe the normal 18 FDG uptake in adult cats. Six adult healthy female cats were used. Cats were sedated and then injected intravenously with 74.0±13.0 (mean±SD) MBq of 18 FDG. General anesthesia was induced and cats were placed in ventral recumbancy on the PET scanner's bed. Static images using multiple bed positions were acquired approximately 60–90 min after injection. A transmission scan was acquired at each bed position utilizing a 57 Co point source to perform attenuation and scatter correction. Regions of interest (ROIs) were drawn over the liver, right and left renal cortices, left ventricular wall, and wall of ascending and descending colonic segments. Standardized uptake values (SUV) were calculated using an established formula. Kidneys and intestinal tract had relatively intense uptake of 18 FDG; liver activity was intermediate; the spleen was not identified in any of the cats. Cardiac activity was variable but intense activity was noted in the left ventricular myocardium in most cats. No appreciable lung uptake was noted. Mean±SD SUV values were calculated. This study established the normal pattern of uptake of 18 FDG in adult cats and provided baseline data for comparison with future studies evaluating a variety of neoplastic and nonneoplastic diseases. 相似文献
2.
Amy K LeBanc Bjoern Jakoby David W Townsend Gregory B Daniel 《Veterinary radiology & ultrasound》2008,49(2):182-188
Positron emission tomography (PET) has found widespread application for staging and monitoring neoplastic diseases in humans. PET is becoming more available in veterinary medicine, therefore biodistribution of 2-deoxy-2-[18F]fluoro-D-glucose (18FDG) in normal dogs is needed for lesion interpretation in disease states. A large field-of-view (FOV) PET scanner with a 70 cm bore diameter and a 53-cm FOV was used in this study to acquire dynamic 18FDG uptake data from parenchymal organs in seven normal dogs. A 2-h, dynamic list-mode acquisition was initiated simultaneously with intravenous 18FDG injection. Regions of interest (ROIs) were manually drawn over liver, spleen, left and right renal cortices, left ventricular free wall, and thymus. Standardized uptake values (SUVs) of these organs were calculated for 24 5-min frames over the 2-h acquisition. This SUV data from parenchymal organs of normal dogs compares favorably with those of normal humans and will be used in ongoing canine studies using PET to evaluate various diseases. 相似文献
3.
AMY K. LEBLANC BJOERN W. JAKOBY DAVID W. TOWNSEND GREGORY B. DANIEL 《Veterinary radiology & ultrasound》2009,50(2):215-223
Positron Emission Tomography (PET) using the glucose analog 2-deoxy-2-[18 F]fluoro- d -glucose (18 FDG) is a common imaging modality for diagnosis and management of many human malignancies. We evaluated 18 FDG-PET in dogs with either multicentric lymphoma (LSA) or cutaneous mast cell tumor (MCT). A prototype large field-of-view PET scanner was used to collect whole-body images in nine dogs with LSA or MCT. Both tumors were characterized by avidity for 18 FDG. In dogs with LSA, 18 FDG-PET correctly identified involvement of superficial and internal lymph nodes, liver, and spleen. Repeated PET scans after induction chemotherapy demonstrated resolution of abnormal 18 FDG uptake within these sites. In dogs with MCT, 18 FDG-PET correctly identified MCT metastasis to regional lymph nodes in all dogs in which this was suspected or confirmed with cytology or biopsy before the PET scan. In two dogs, additional sites of mast cell disease were identified with 18 FDG-PET that were undetected on physical examination and/or regional lymph node cytology. 18 FDG-PET holds promise as a whole-body staging method for canine LSA and MCT. 相似文献
4.
Philip D. Koblik DVM MS Chi-Kwan Yen MD Jan Komtebedde DVM William J. Hornof DVM MS Peter F. Moore BvSc PhD Paul E. Fisher MS 《Veterinary radiology & ultrasound》1990,31(4):170-174
Shunt fraction was determined using transcolonic 123 I-iodoamphetamine (IMP) and portal vein injection of 99m Tc-macroaggregated albumin (MAA) in a group of eight dogs with chronic cirrhosis and acquired portosystemic shunts subsequent to total common bile duct ligation. Hepatic parenchymal damage was confirmed by alterations in liver function tests and liver histology. Seven of the eight dogs developed portal hypertension and had angiographic evidence of hepatofugal portal blood flow with multiple peripheral portosystemic anastomoses. Shunt fractions determined in the seven dogs with shunts varied from 39 to 100 using IMP and 45 to 93 using MAA. The remaining dog had normal portal pressure, a normal portal angiogram, and normal IMP and MAA scintigraphic studies. There was an excellent correlation between the two methods of shunt fraction calculation (R2 = 0.98) and the line of regression was not significantly different from unity (IMP = 1.09 × MAA - 0.03). 相似文献
5.
JESSICA LAWRENCE MATTHEW VANDERHOEK DAVID BARBEE ROBERT JERAJ DANIEL B. TUMAS DAVID M. VAIL 《Veterinary radiology & ultrasound》2009,50(6):660-668
Imaging and measurement of proliferation with computed tomography (CT) and positron emission tomography (PET) provide a noninvasive method for improved staging and monitoring of response to cancer treatment. We evaluated prospectively the proliferation marker 3'-deoxy-3'[18 F] fluorothymidine (FLT) in the context of FLT-PET/CT for detection of early response, confirmation of posttreatment response, and prediction of relapse in dogs with non-Hodgkin's lymphoma. Nine dogs with non-Hodgkin's lymphoma who were scheduled to receive five cycles of an investigational cytotoxic chemotherapy agent were included. All dogs received baseline FLT-PET/CT imaging immediately before chemotherapy. Intent was to repeat imaging with FLT-PET/CT at various time points: group 1 ( n =4), 5 days after initiation of chemotherapy and 3 weeks following the last chemotherapy administration; group 2 ( n =5), before the fourth cycle of chemotherapy and 3 weeks following the last administration. Two dogs in group 2 did not undergo repeat PET/CT. Body mass standardized uptake values (SUV) for FLT were calculated for each dog. Eight dogs had initially increased FLT uptake (mean SUVmax =9.8 [2.6–22.3]). Mean SUV decreased significantly for the seven dogs that underwent follow-up PET/CT following chemotherapy (mean SUVmax =3.5 [1.1–7.9], P <0.016). Increased uptake preceded clinical and cytological evidence of relapse in two dogs. Ki-67 immunohistochemistry confirmed decreased proliferation corresponding to decreased SUV in three canine lymph node samples. FLT-PET/CT functional and anatomical imaging shows promise for the evaluation of response to cytotoxic chemotherapy in dogs with non-Hodgkin's lymphoma and for predicting relapse before standard clinical and clinicopathologic confirmation. 相似文献
6.
William H. Adams DVM Michael A. Walker DVM Gregory B. Daniel DVM MS Mark G. Petersen DVM MA Alfred M. Legendre DVM MS 《Veterinary radiology & ultrasound》1995,36(5):417-424
Seven dogs with thyroid gland carcinoma were treated with 131 I and hormone suppressive therapy either alone (3 dogs) or in combination with surgery (3 dogs) or 137 Cs teletherapy and chemotherapy (1 dog). Empirically chosen doses of 75 to 137 mCi of 131 I were given orally (2 dogs) and intravenously (5 dogs). Adverse effects were limited to acute, transient bone marrow hypoplasia and pancytopenia. Nominal objective reduction in tumor volume or size and number of pulmonary metastases was observed in 4 dogs treated with 131 I and thyroxine. Of these 4 dogs, 2 had stable disease for periods of 4 and 12 months while a third dog had stable disease for 27 months following two 131 I treatments at 3 month intervals. The fourth dog had progressive disease. Two dogs with mediastinal metastases showed reduction in localization of 99m Tc pertechnetate and radioiodine following 2 and 3 treatments using 131 I. It appears that relatively high doses of 131 I can be used safely for the treatment of canine thyroid tumors and that further investigation can be justified to define its efficacy. 相似文献
7.
Clifford R. Berry DVM W. Grant Guilford BVSc PhD Philip D. Koblik DVM MS William H. Hornof DVM MS Paul Fisher BS. 《Veterinary radiology & ultrasound》1997,38(3):221-225
The purpose of this sutdy was to determine the clinical utility of 111 In-labeled transferrin ( 111 In-TF) scintigraphy for evaluating dogs suspected of having protein-losing enteropathies. Four dogs were injected intravenoulsy with autologous 111 In-TF after 30 min incubation (at 37°C) of 18.5 MBq (0.5mCi) 111 In CI3 with one ml of autologous plasma, Serial right lateral, left lateral and dorsal images were obtained 2, 4, and 24 hours post 111 In-TF administration, Images were subjectively evaluated for the presence or absence of 111 within the gastrointestinal tract. The results of total protein, albumin and globulin legels and results form gastrointestinal tract. the results of total protein, albumin and globulin levels and results from gastrointestinal biopsies were recorded. In one dog, a follow-up scientigraphic study was done six months after initial evaluation and initiation of treatment for plasmocytic-lymphocytic enteritis. Gastrointestinal activity was noted by two hours in two dogs, while all four dogs had gastrointestinal activity on the 24 hour images. The mean (±std dev) plasma protein, albumin and globulin levels were 3.5 (±0.9), 1.7 (±1) and 1.8 (±0.3) respectively at the time of initial presentation. In the one dog that was evaluated after therapy, faint visualization of radioactivity within the colon was noted on the 24 hour image. Based on this study, 111 In-TF appears to be a viable scientigraphic method for evaluating dogs with suspected dogs withfd suspected protein-losing enteropathies, Potential limitations of tjis radiopharmaceutical include cost and prolonged isolation of the animal prior to release to the client due to the long physical half-life (T½ = 2.82 days). 相似文献
8.
J. Turrel B. Burke S. Ullman M. McEntee R. Page 《Veterinary and comparative oncology》2005,3(1):52-53
Introduction: Greater than 50% of dogs with thyroid tumors present with surgically unresectable disease for which external beam radiotherapy has been reported to prolong survival. The success of 131 I for control of thyroid tumors in cats and in humans suggests such therapy may also play a role in the management of canine thyroid cancer.
Methods: Thirty‐nine dogs with WHO stage II/III (invasive or ectopic; n = 32) or IV (metastatic; n = 7) thyroid tumors were treated with131 I alone. Changes in thyroid function, 99M Tc‐pertechnetate (99M Tc) scintigraphic changes, and tumor response were recorded. Dogs with ventral cervical tumors were evaluated for feasibility of surgical resection following 131 I.
Results: Median overall survival was 839 days and 366 days for dogs with stage II/III and stage IV tumors, respectively. Thyroid hormone status, site and surgical resection were not associated with outcome in dogs with stage II/III tumors. Three dogs developed severe bone marrow suppression.
Conclusions: These findings suggest131 I should be investigated more thoroughly in dogs with thyroid tumors not considered surgical candidates to more clearly characterize the indications for therapy and followup recommendations. 131 I dosimetry in dogs with thyroid tumors remains problematic. Administration of 131 I is currently based on empiric recommendations and, in general, the treatment is well tolerated although additional studies are indicated to optimize response and minimize toxicity. 相似文献
Methods: Thirty‐nine dogs with WHO stage II/III (invasive or ectopic; n = 32) or IV (metastatic; n = 7) thyroid tumors were treated with
Results: Median overall survival was 839 days and 366 days for dogs with stage II/III and stage IV tumors, respectively. Thyroid hormone status, site and surgical resection were not associated with outcome in dogs with stage II/III tumors. Three dogs developed severe bone marrow suppression.
Conclusions: These findings suggest
9.
Philip D. Koblik DVM MA Chi-K Yen MD William J. Hornof DVM MS Pamela Whiting DVM Paul Fisher BS 《Veterinary radiology & ultrasound》1989,30(2):67-73
Transcolonic 123 I-Iodoamphetamine is rapidly absorbed across the colonic mucosa and binds to amine receptors in the liver and lungs. During the first ten minutes following colonic administration, a simple ratio of lung counts to lung counts plus liver counts provides an accurate estimate of the fraction of portal blood that bypasses hepatic sinusoids in dogs with portosystemic shunts. Studies were performed on 24 dogs with suspect portosystemic shunt. Shunt fraction values for 18 dogs with surgically confirmed portosystemic shunt were obviously higher than published values for normal dogs, and also significantly higher than values for the other six dogs, later confirmed to lack shunts. Postoperative studies were repeated on ten dogs with single shunt vessels 1–2 days after shunt closure. Total shunt ligation resulted in normal postoperative shunt fraction, whereas partial shunt ligation resulted in persistant elevation of shunt fraction. Transcolonic iodoamphetamine scintigraphy is noninvasive, easy to perform, and provides an accurate method to diagnose dogs with portosystemic shunt. 相似文献
10.
Ariana M.P. Nap Yvonne W.E.A. Pollak Walter E. van den Brom Ad Rijnberk DVM PhD 《Journal of veterinary internal medicine / American College of Veterinary Internal Medicine》1994,8(4):302-303
Thyroidal 99m TcO4 (pertechnetate) uptake percentages were determined in unanesthetized euthyroid (n = 13) and hyperthyroid (n = 18) cats. Maximal uptakes were observed 60 minutes after IV injection of the radionuclide and ranged from 0.3 to 3.9% of the dose in euthyroid cats (median 2.23%) and from 5.2% to 23.9% of the dose in hyperthyroid cats (median 14.8%) ( P < .05). There were no overlaps in pertechnetate uptake percentages during any of the intervals evaluated. It is concluded that the optimal time for visualization of the thyroid by 99m TcO4 -scanning is 60 minutes after IV injection of the radionuclide. Calculation of the percentage uptake is of additional diagnostic value. 相似文献
11.
Clifford R. Berry DVM Kathy N. Wright DVM Edward B. Breitschwerdt DVM Jerome M. Feldman MD 《Veterinary radiology & ultrasound》1993,34(1):52-55
A 13-year-old neutered female Yorkshire terrier presented with a history of progressive episodic weakness and disorientation of 4 months duration. Physical and neurologic examinations were normal at presentation. Abdominal ultrasound revealed a mass involving the right adrenal gland. Standard planar scintigraphy was performed at 4, 18, and 24 hours after intravenous injection 185 MBq (5mCi) of 123 I-labeled metaiodobenzylguanidine (123 I-MIBG). An area of focal intense uptake was identified in the area of the right adrenal gland. A pheochromocytoma was confirmed histologically after surgical excision. 相似文献
12.
Quantitative hepatobiliary scintigraphy using 99m Tc-2,6 diisopropylphenylcarbamoylmethyl iminodiacetic acid (DISIDA) was performed in normal dogs. 99m Tc-DISIDA is excreted by the hepatocyte into the biliary tract. Hepatic blood flow from arterial and portal venous sources was measured as the hepatic perfusion index. The hepatic clearance of the radiopharmaceutical was used to assess hepatocyte function and parenchymal biliary transport. Biliary ejection was evaluated using synthetic cholecystokinin infusion. The procedure should be useful in evaluating dogs with hepatic and biliary disease. 相似文献
13.
Clifford R. Berry DVM Timothy R. Degrado PhD Felicia Nutter DVM Pradeep K. Garg PhD Edward B. Breitschwerdt DVM MS Kathy Spaulding DVM Kevin D. Concannon DVM Michael R. Zalutsky PhD R. Edward Coleman MD 《Veterinary radiology & ultrasound》2002,43(2):183-186
p-[18F]Fluorobenzylguanidine ([18F]PFBG) is a norepinephrine analog that has been developed as a positron emission tomography (PET) imaging radiopharmaceutical. Myocardial sympathetic innervation, neuroendocrine structures, and tumors can be noninvasively imaged with [18F]PFBG. In this study, the uptake characteristics of [18F]PFBG were investigated in 2 dogs with a spontaneous pheochromocytoma. The extent of the pheochromocytoma was well documented in both dogs on the PET study. The standardized uptake values within the pheochromocytomas were greater than 25 by 10 min, and were 37 and 50 by 45 min in each dog. A third dog that was suspected to have an adrenal mass was also studied. In this dog, the [18F]PFBG study was normal. Surgical exploration and adrenal biopsy confirmed the [15F]PFBG imaging findings in both dogs. In each dog, there was rapid blood-pool clearance (within 10 min after intravenous administration of the [18F]PFBG), with high uptake specific within the myocardium and adrenal medulla. The results indicate that [18F]PFBG may be useful for imaging canine pheochromocytomas and aid in differentiating adrenal masses. 相似文献
14.
Phillip F. Steyn BVSc MRCVS MS Gregory Ogilvie DVM 《Veterinary radiology & ultrasound》1995,36(5):411-416
Technetium-99m methoxy-isobutyl-isonitrile (sestamibi) imaging of malignant canine lymphoma was performed in thirteen dogs 1 hour after intravenous injection of 99m Tc-sestamibi at 13 MBq (0.35 mCi) per kilogram body weight. Abnormal tracer uptake was visualized in the liver, spleen, bone marrow, and mesenteric, inguinal, popliteal, sternal, cranial cervical and mandibular lymph nodes. Radiopharmaceutical uptake was also noted in a nasal mass. One large neoplastic renal mass did not have demonstrable sestamibi uptake. Other regions had no significant difference in the target:background ratios when compared with values from normal dogs ( P > 0.05). 99m Tc-sestamibi can be used to image malignant lymphoma, and has potential applications in the management of patients to document response to treatment and to stage of extent of disease. 相似文献
15.
E. Vandermeulen I. van Hoek C. De Sadeleer A. Piepsz H.R. Ham T. Bosmans A. Dobbeleir S. Daminet K. Peremans 《Journal of veterinary internal medicine / American College of Veterinary Internal Medicine》2008,22(2):266-272
Background: Chronic kidney failure is frequently seen in middle-aged and elderly cats. 51 Chromium-ethylene diaminic tetraacetic acid (51 Cr-EDTA) clearance and single blood sample (SBS) method are used in several species to estimate the glomerular filtration rate (GFR).
Hypothesis: The hypothesis of this study was that51 Cr-EDTA clearance could be determined using an SBS method in normal and hyperthyroid cats.
Animals: Forty-six cats were included in this study, with an average age of 9.5 years. Of these cats, 27 had hyperthyroidism; 19 were healthy.
Methods: After IV injection of51 Cr-EDTA (average dose: 4.25 MBq), 7 blood samples were obtained between 5 and 240 minutes. Reference clearance was calculated in mL/min and mL/min/kg body weight, using a 2-compartment model. Optimal time for clearance measurement with SBS was then determined by systematically comparing each individual plasma concentration to the reference multisample clearance.
Results: The average reference plasma clearance of51 Cr-EDTA for all cats was 14.9 mL/min (3.7 mL/min/kg). The clearance in hyperthyroid cats averaged 16.4 mL/min (4.3 mL/min/kg) and in normal cats averaged 10.3 mL/min (2.4 mL/min/kg).
The optimal time for the SBS was 48 minutes after injection of tracer51 Cr-EDTA ( R 2 = 0.9414), giving the following converting equation: clearance = (0.0066 × DV48 minutes ) – 0.9277 (in mL/min).
Conclusions and Clinical Importance: In this study, the single sample51 Cr-EDTA clearance method was used to estimate the global GFR in cats. The method identified differences in clearance between normal and hyperthyroid cats. The optimal time for an SBS was 48 minutes. 相似文献
Hypothesis: The hypothesis of this study was that
Animals: Forty-six cats were included in this study, with an average age of 9.5 years. Of these cats, 27 had hyperthyroidism; 19 were healthy.
Methods: After IV injection of
Results: The average reference plasma clearance of
The optimal time for the SBS was 48 minutes after injection of tracer
Conclusions and Clinical Importance: In this study, the single sample
16.
Gregory B. Daniel DVM MS Ronald Bright DVM MS Eric Monnet DVM Paul Ollis RT 《Veterinary radiology & ultrasound》1990,31(4):175-181
Per-rectal portal scintigraphy using tech-netium-99m pertechnetate (99m TcO4 - ) was performed in 8 normal dogs before and after surgical creation of a portacaval shunt. Shunt fractions were calculated by computer assisted analysis of dynamic images (IMG) and compared to shunt fractions determined by mesenteric venous injection of radioactive microspheres (MIC). The mean pre-operative shunt fraction was 1.59% using IMG and 3.00% using MCI. The mean postoperative shunt fraction was 64.56% using IMG and 69.56% using MIC. There was excellent correlation between both methods (r2 0.94). Per-rectal portal scintigraphy is an easily performed, inexpensive method to diagnose and quantify portosystemic shunts in dogs. 相似文献
17.
Christopher R. Lamb MA VetMB MRCVS Scott H. Schelling DVM John Berg DVM MS 《Veterinary radiology & ultrasound》1989,30(6):268-271
Localization of 99m Tc-MDP in lymph nodes was apparent on the three-hour bone-scan image in seven dogs. In six dogs injection or leakage of the radiopharmaceutical into the perivascular tissues was associated with subsequent uptake in an ipsilateral lymph node. In the remaining dog, 99m Tc-MDP localized in a lymph node infiltrated by metastatic osteosarcoma. This aided staging of the tumor. Possible mechanisms of 99m Tc-MDP localization in soft tissues are briefly reviewed. 相似文献
18.
MARTIN HOFSTETTER DVM PHILIPPE GÉDET Diplom-HTL-Ingenieur MARCUS DOHERR Diplomate ECVPH STEPHEN J. FERGUSON PhD FRANCK FORTERRE Diplomate ECVS 《Veterinary surgery : VS》2009,38(1):49-58
Objective— To study the kinematics of cervical spine segment C4 –C5 and its association with disc dimensions and the coupled motion (CM) in relation to primary motion (PM).
Study Design— Cadaveric biomechanical study.
Animals— Cadavers of large breed dogs (>20 kg; n=11).
Methods— Spines were freed from muscles. Radiographs were taken orthogonal to the C4 –C5 disc space and disc thickness, endplate width, and height were measured. Spines were mounted on a simulator for 3-dimensional motion analysis. Data were recorded with an optoelectronic motion analysis system. Range of motion (ROM) and neutral zone (NZ) were determined in the direction of flexion/extension, left/right lateral bending, and left/right axial rotation, as well as the ROM of CM.
Results— ROM in flexion and extension was similar; there was no CM in flexion/extension. Left/right axial rotation and left/right lateral bending were coupled to the same side. CM was 1.72 and 3.56 times the ROM of the PM in lateral bending and axial rotation, respectively. Disc dimensions were positively correlated with body weight. Flexion/extension magnitude was significantly reduced for larger endplates, but axial rotation was not influenced. Lateral bending had no correlation with weight or disc dimensions.
Conclusion— Left/right lateral bending and left/right axial rotation are coupled differently in the C4 –C5 segment in dogs compared with humans.
Clinical Relevance— The canine C4 –C5 spinal segment has unique motion coupling patterns that should be considered for dynamic implant designs. 相似文献
Study Design— Cadaveric biomechanical study.
Animals— Cadavers of large breed dogs (>20 kg; n=11).
Methods— Spines were freed from muscles. Radiographs were taken orthogonal to the C
Results— ROM in flexion and extension was similar; there was no CM in flexion/extension. Left/right axial rotation and left/right lateral bending were coupled to the same side. CM was 1.72 and 3.56 times the ROM of the PM in lateral bending and axial rotation, respectively. Disc dimensions were positively correlated with body weight. Flexion/extension magnitude was significantly reduced for larger endplates, but axial rotation was not influenced. Lateral bending had no correlation with weight or disc dimensions.
Conclusion— Left/right lateral bending and left/right axial rotation are coupled differently in the C
Clinical Relevance— The canine C
19.
Mit dem mikroautoradiographischen Verfahren unter Einsatz von /3 H-Aktynomyzin/ 3 H-AMD/ wurde bereits im Verlauf des Einfriervorganges eine Störung des Gleichgewichtszustandes im Bereich der DNP-Komplexe des Spermienkopfes ermittelt. Diese Erscheinung zeigt sich in einer ansteigenden Anzahl von Einschlussen von 3 H-AMD. Es wurde eine Abhängigkeit dieses Proresses aber nicht nur von den Einfrierphasen, sondern auch vom Alter der Bullen und der Zeitdauer der Konservierung des Spermas nachgewiesen. Die niedrigsten Werte der Einschlüsse von 3 H-AMD wurden bei einer Aufbewahrungsdauer der Spermienproben von 3 Monaten bis 5 Jahre ermittelt. Die aus den 6–9 Jahre aufbewahrten Samenproben gewonnenen Spermien waren durch einen hohen Markierungsgrad charakterisiert, was auf Störungen der elektrostatischen Einwirkungen zwischen DNP und Kernproteinen dieser Samenzellen hindeutet . 相似文献
20.
MANUEL PINILLA ROBERT E. SHIEL SHEILA F. BRENNAN HESTER McALLISTER CARMEL T. MOONEY 《Veterinary radiology & ultrasound》2009,50(2):224-229
The existence of hypothyroidism in greyhounds remains controversial and its investigation is complicated by the low circulating thyroid hormone concentrations typically found in healthy dogs of this breed. Quantitative measurement of thyroidal technetium-99m pertechnetate (99m TcO4 − ) uptake is known to be useful in assessing thyroid function in other breeds. The aim of this study was to evaluate thyroid scintigraphy as a method of assessing thyroid function in greyhounds suspected of primary hypothyroidism. Twenty greyhounds (eight females, 12 males) were studied. Thirteen had bald thigh syndrome and seven poor performance and low total T4. Total T4 concentrations were decreased in 18 (90%), and free T4 in two (10%) dogs. All canine thyroid stimulating hormone concentrations were within the reference interval. Thyroidal 99m TcO4 − uptake values (mean ± SD, 0.76 ± 0.26%) were within the reference limits published for euthyroid dogs (0.39–1.86%) making hypothyroidism highly unlikely. There were no significant differences ( P <0.05) when comparing data between dogs with bald thigh syndrome (13 dogs) and the remaining dogs (seven dogs). Seventeen (85%) dogs had higher uptake in the left thyroid gland than in the right that might reflect an anatomic feature of the greyhound breed. Calculation of percent thyroidal uptake of 99m TcO4 − is more accurate than thyroid:salivary gland ratios because of high variability in salivary gland uptake. Percent thyroidal uptake of 99m TcO4 − should be used when assessing thyroid function scintigraphically in the greyhound breed. 相似文献